Wikidata

(Q113918264)

English

Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A MULTI-CENTER CONTINUATION STUDY EVALUATING AZACITIDINE WITH OR WITHOUT GLASDEGIB (PF-04449913) IN PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA, MYELODYSPLASTIC SYNDROME OR CHRONIC MYELOMONOCYTIC LEUKEMIA (English)
0 references
country
Austria
0 references
Canada
0 references
France
0 references
Hungary
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Poland
0 references
Spain
0 references
United Kingdom
0 references
start time
17 May 2021
0 references
end time
16 December 2022
0 references
number of participants
15
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113918264&oldid=2243093164"